Velu T - Search Results

1

A novel method for the titration of recombinant virus stocks by ELISPOT assay.

Cheong SC, Clément N, Velu T, Brandenburger A. Cheong SC, et al. Among authors: velu t. J Virol Methods. 2003 May;109(2):119-24. doi: 10.1016/s0166-0934(03)00061-2. J Virol Methods. 2003. PMID: 12711053

2

Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids.

Clément N, Velu T, Brandenburger A. Clément N, et al. Among authors: velu t. Cancer Gene Ther. 2002 Sep;9(9):762-70. doi: 10.1038/sj.cgt.7700496. Cancer Gene Ther. 2002. PMID: 12189526

3

In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.

El Bakkouri K, Servais C, Clément N, Cheong SC, Franssen JD, Velu T, Brandenburger A. El Bakkouri K, et al. Among authors: velu t. J Gene Med. 2005 Feb;7(2):189-97. doi: 10.1002/jgm.653. J Gene Med. 2005. PMID: 15515141

4

Cloning and sequencing of defective particles derived from the autonomous parvovirus minute virus of mice for the construction of vectors with minimal cis-acting sequences.

Clément N, Avalosse B, El Bakkouri K, Velu T, Brandenburger A. Clément N, et al. Among authors: velu t. J Virol. 2001 Feb;75(3):1284-93. doi: 10.1128/JVI.75.3.1284-1293.2001. J Virol. 2001. PMID: 11152501 Free PMC article.

5

Generation of cell hybrids via a fusogenic cell line.

Cheong SC, Blangenois I, Franssen JD, Servais C, Phan V, Trakatelli M, Bruyns C, Vile R, Velu T, Brandenburger A. Cheong SC, et al. Among authors: velu t. J Gene Med. 2006 Jul;8(7):919-28. doi: 10.1002/jgm.906. J Gene Med. 2006. PMID: 16602137

6

Hypoxic-response elements in the oncolytic parvovirus Minute virus of mice do not allow for increased vector production at low oxygen concentration.

Servais C, Caillet-Fauquet P, Draps ML, Velu T, de Launoit Y, Brandenburger A. Servais C, et al. Among authors: velu t. J Gen Virol. 2006 May;87(Pt 5):1197-1201. doi: 10.1099/vir.0.81754-0. J Gen Virol. 2006. PMID: 16603521

7

Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.

Brandenburger A, Velu T. Brandenburger A, et al. Among authors: velu t. J Gene Med. 2004 Feb;6 Suppl 1:S203-11. doi: 10.1002/jgm.504. J Gene Med. 2004. PMID: 14978763 Review.

8

Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors.

Brandenburger A, Coessens E, El Bakkouri K, Velu T. Brandenburger A, et al. Among authors: velu t. Hum Gene Ther. 1999 May 1;10(7):1229-38. doi: 10.1089/10430349950018210. Hum Gene Ther. 1999. PMID: 10340554

9

[The medical oncology clinic].

Velu T, Brandenburger A, Bruyns C, Gangji D, Tenenbaum L. Velu T, et al. Rev Med Brux. 2002;23 Suppl 2:131-6. Rev Med Brux. 2002. PMID: 12584929 Review. French.

10

Cellular contaminants of adeno-associated virus vector stocks can enhance transduction.

Tenenbaum L, Hamdane M, Pouzet M, Avalosse B, Stathopoulos A, Jurysta F, Rosenbaum C, Hanemann CO, Levivier M, Velu T. Tenenbaum L, et al. Among authors: velu t. Gene Ther. 1999 Jun;6(6):1045-53. doi: 10.1038/sj.gt.3300904. Gene Ther. 1999. PMID: 10455407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters